Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months

• Autori principali: Scilla Sparabombe (Autore), Lucia Vitali (Autore), Alessandra Nori (Autore), Ricarda Sara Berlin (Autore), Marta Mazur (Autore), Giovanna Orsini (Autore), Angelo Putignano (Autore)
• Natura: Libro
• Pubblicazione: Hindawi Limited, 2014-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Objectives. Bisphosphonates related osteonecrosis of the jaw (BRONJ) is a pathological condition characterized by bone exposure or latent infection in patients treated with the drug. The aim of the study is to monitor the BRONJ level of risk health in patients with cancer, according to a preventive...